Virtu Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,727
| Closed | -$118K | – | 1442 |
|
|
2025
Q1 | $118K | Buy |
14,727
+4,074
| +38% | +$32.6K | 0.01% | 904 |
|
|
2024
Q4 | $96K | Buy |
+10,653
| New | +$96K | 0.01% | 1030 |
|
|
2024
Q3 | – | Sell |
-54,102
| Closed | -$309K | – | 1359 |
|
|
2024
Q2 | $309K | Buy |
54,102
+38,511
| +247% | +$220K | 0.02% | 587 |
|
|
2024
Q1 | $78K | Buy |
+15,591
| New | +$78K | 0.01% | 958 |
|
|
2023
Q3 | – | Sell |
-15,795
| Closed | -$153K | – | 1291 |
|
|
2023
Q2 | $153K | Buy |
+15,795
| New | +$153K | 0.01% | 901 |
|
|
2023
Q1 | – | Sell |
-30,873
| Closed | -$133K | – | 1521 |
|
|
2022
Q4 | $133K | Buy |
+30,873
| New | +$133K | 0.02% | 855 |
|
|
2022
Q3 | – | Sell |
-20,658
| Closed | -$208K | – | 1715 |
|
|
2022
Q2 | $208K | Buy |
20,658
+805
| +4% | +$8.11K | 0.02% | 749 |
|
|
2022
Q1 | $246K | Buy |
+19,853
| New | +$246K | 0.02% | 676 |
|
|
2021
Q3 | – | Sell |
-67,123
| Closed | -$870K | – | 1492 |
|
|
2021
Q2 | $870K | Buy |
+67,123
| New | +$870K | 0.08% | 247 |
|
|
2019
Q4 | $412K | Sell |
20,326
-2,462
| -11% | -$49.9K | 0.04% | 507 |
|
|
2019
Q3 | $122K | Buy |
+22,788
| New | +$122K | 0.01% | 1049 |
|
|
2019
Q1 | – | Sell |
-15,458
| Closed | -$105K | – | 1390 |
|
|
2018
Q4 | $105K | Buy |
+15,458
| New | +$105K | 0.01% | 1111 |
|
|
2018
Q3 | – | Sell |
-17,511
| Closed | -$99K | – | 1522 |
|
|
2018
Q2 | $99K | Buy |
+17,511
| New | +$99K | 0.01% | 1644 |
|
|
2017
Q4 | – | Sell |
-37,009
| Closed | -$232K | – | 2349 |
|
|
2017
Q3 | $232K | Buy |
+37,009
| New | +$232K | 0.01% | 1669 |
|